Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04437225 · ClinicalTrials.gov registry record · NA

Renal Metabolism of Glycolate to Oxalate

A NA study of Healthy, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT04437225 is a NA study of Healthy that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 15 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04437225, a NA study of Healthy, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This study will determine the contribution of glycolate metabolism to urinary oxalate excretion in healthy subjects, using carbon 13 isotope glycolate tracer technique and a low-oxalate controlled diet.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Low oxalate controlled Diet
  • OTHER Primed, continuous intravenous infusion of 13C2-Glycolate
  • OTHER Bolus intravenous infusion of 13C2-Glycolate
  • OTHER Oral bolus administration of 13C2-Glycolate

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2020-03-12
Est. Completion 2027-09-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04437225

The ClinicalTrials.gov registry entry for NCT04437225 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which Low oxalate controlled Diet is the first listed.

NCT04437225 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT04437225 about?

NCT04437225 is a clinical study titled "Renal Metabolism of Glycolate to Oxalate". This study will determine the contribution of glycolate metabolism to urinary oxalate excretion in healthy subjects, using carbon 13 isotope glycolate tracer technique and a low-oxalate controlled diet.

What is the current status of trial NCT04437225?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2020-03-12. Estimated completion is 2027-09-01.

What conditions does trial NCT04437225 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT04437225?

The interventions under investigation include: Low oxalate controlled Diet (DIETARY_SUPPLEMENT), Primed, continuous intravenous infusion of 13C2-Glycolate (OTHER), Bolus intravenous infusion of 13C2-Glycolate (OTHER), Oral bolus administration of 13C2-Glycolate (OTHER).

Who is sponsoring clinical trial NCT04437225?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04437225 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.